ImmunityBio, Inc. — Director's Dealing 2018

May 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2018-05-15

Reporting Person: GORLIN STEVE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-15	Common Stock	S	26835	$4.1323	Disposed	494885	Indirect
2018-05-16	Common Stock	S	16200	$4.0515	Disposed	478685	Indirect
2018-05-17	Common Stock	S	38708	$4.0025	Disposed	439977	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	246280	Direct

Footnotes

F1: Represents the weighted average share price of an aggregate total of 26,835
shares sold in the price range of $4.08 to $4.20 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Represents the weighted average share price of an aggregate total of 16,200 shares sold in the price range of $4.04 to $4.11 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 38,708 shares sold in the price range of $4.00 to $4.03 by the reporting person's spouse. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.